USMJ Prepares To Kickoff Cannabis Ecommerce Expansion Campaign
North American Cannabis Holdings, known by the stock symbol USMJ, announced a strategic expansion of its cannabis ecommerce business, set to commence in February 2022. This initiative follows a refocus by its controlling shareholder, ACI Conglomerated, which also oversees Puration, Inc. and Priority Aviation, Inc. USMJ is pivoting from the cannabis retail restaurant market to enhance its online presence, aiming to broaden its ecommerce footprint. Stakeholders are encouraged to visit their website for further updates.
- Initiating a major expansion of cannabis ecommerce.
- Strategic shift away from cannabis retail restaurants.
- Increased focus on enhancing online sales presence.
- Risks associated with the expansion include market competition.
- Uncertainties about achieving significant sales.
- Financial resources may limit growth potential.
Dallas, TX, Feb. 03, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced the company is ready at the starting line to kickoff a major expansion of its cannabis ecommerce business.
In September of last year, ACI Conglomerated, the controlling shareholder of USMJ and the controlling shareholder of Puration, Inc. (OTC Pink: PURA) and Priority Aviation, Inc. (OTC Pink: PJET), announced its plans to refocus and diversify its overall strategy with the three companies.
PJET diversified outside the cannabis industry entering the student life market.
PURA refocused its business on industrial hemp.
USMJ, after exiting the cannabis retail restaurant market, is not focused on expanding its cannabis ecommerce footprint. February will be the kickoff of its expansion campaign.
Visit the company’s ecommerce site now and bookmark the site to watch for coming announcements and updates:
Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
FAQ
What is the focus of North American Cannabis Holdings' expansion?
When will USMJ's ecommerce expansion begin?
Who is the controlling shareholder of USMJ?